OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Severe progression of idiopathic pulmonary fibrosis post-COVID-19 infection
N Earl, Dillon Schoeneberg, Philip D Davidson
BMJ Case Reports (2021) Vol. 14, Iss. 10, pp. e244472-e244472
Open Access | Times Cited: 7
N Earl, Dillon Schoeneberg, Philip D Davidson
BMJ Case Reports (2021) Vol. 14, Iss. 10, pp. e244472-e244472
Open Access | Times Cited: 7
Showing 7 citing articles:
Inpatient rehabilitation for a patient with COVID-19 exacerbation of pulmonary fibrosis: a case report
Heather McKenna, Erin Y. Harmon
Journal of Rehabilitation Medicine – Clinical Communications (2025) Vol. 8, pp. jrmcc40698-jrmcc40698
Open Access
Heather McKenna, Erin Y. Harmon
Journal of Rehabilitation Medicine – Clinical Communications (2025) Vol. 8, pp. jrmcc40698-jrmcc40698
Open Access
COVID-19-Triggered Acute Exacerbation of IPF, an Underdiagnosed Clinical Entity With Two-Peaked Respiratory Failure: A Case Report and Literature Review
Yosuke Goto, Koji Sakamoto, Jun Fukihara, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 11
Yosuke Goto, Koji Sakamoto, Jun Fukihara, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 11
Ongoing Clinical Trials in Aging-Related Tissue Fibrosis and New Findings Related to AhR Pathways
Hangxing Yu, Zhe Feng, Wei Lin, et al.
Aging and Disease (2022) Vol. 13, Iss. 3, pp. 732-732
Open Access | Times Cited: 6
Hangxing Yu, Zhe Feng, Wei Lin, et al.
Aging and Disease (2022) Vol. 13, Iss. 3, pp. 732-732
Open Access | Times Cited: 6
No increased prevalence of autoantibodies neutralizing type I IFNs in idiopathic pulmonary fibrosis patients
Quentin Philippot, Paul Bastard, Anne Puel, et al.
Respiratory Research (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Quentin Philippot, Paul Bastard, Anne Puel, et al.
Respiratory Research (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 2
COVID-19 in patients with interstitial lung disease
Eirini Vasarmidi, Pierre Le Guen, Tiphaine Goletto, et al.
European Respiratory Society eBooks (2024)
Closed Access
Eirini Vasarmidi, Pierre Le Guen, Tiphaine Goletto, et al.
European Respiratory Society eBooks (2024)
Closed Access
In Silico analysis unveils rs2109069 of DPP9 as a potential catalyst for COVID-19 severity and risk of inflammatory symptoms
Chi‐Ying Lee, Zih‐Yin Lai, Yung‐Jen Chuang
Experimental and Molecular Pathology (2024) Vol. 140, pp. 104946-104946
Open Access
Chi‐Ying Lee, Zih‐Yin Lai, Yung‐Jen Chuang
Experimental and Molecular Pathology (2024) Vol. 140, pp. 104946-104946
Open Access
Enigma of categorizing COVID-19-related lung parenchymal diseases and management experience with follow-up outcomes in Qatar: a case series
Phool Iqbal, Muhammad Jamshaid, Aamir Shahzad, et al.
Qatar medical journal (2022) Vol. 2022, Iss. 1
Open Access
Phool Iqbal, Muhammad Jamshaid, Aamir Shahzad, et al.
Qatar medical journal (2022) Vol. 2022, Iss. 1
Open Access
